243 related articles for article (PubMed ID: 20966392)
21. Short communication: flecainide exerts an antiarrhythmic effect in a mouse model of catecholaminergic polymorphic ventricular tachycardia by increasing the threshold for triggered activity.
Liu N; Denegri M; Ruan Y; Avelino-Cruz JE; Perissi A; Negri S; Napolitano C; Coetzee WA; Boyden PA; Priori SG
Circ Res; 2011 Jul; 109(3):291-5. PubMed ID: 21680895
[TBL] [Abstract][Full Text] [Related]
22. β-Adrenergic stimulation increases the intra-sarcoplasmic reticulum Ca2+ threshold for Ca2+ wave generation.
Domeier TL; Maxwell JT; Blatter LA
J Physiol; 2012 Dec; 590(23):6093-108. PubMed ID: 22988136
[TBL] [Abstract][Full Text] [Related]
23. EL20, a potent antiarrhythmic compound, selectively inhibits calmodulin-deficient ryanodine receptor type 2.
Klipp RC; Li N; Wang Q; Word TA; Sibrian-Vazquez M; Strongin RM; Wehrens XHT; Abramson JJ
Heart Rhythm; 2018 Apr; 15(4):578-586. PubMed ID: 29248564
[TBL] [Abstract][Full Text] [Related]
24. Nitric oxide-dependent activation of CaMKII increases diastolic sarcoplasmic reticulum calcium release in cardiac myocytes in response to adrenergic stimulation.
Curran J; Tang L; Roof SR; Velmurugan S; Millard A; Shonts S; Wang H; Santiago D; Ahmad U; Perryman M; Bers DM; Mohler PJ; Ziolo MT; Shannon TR
PLoS One; 2014; 9(2):e87495. PubMed ID: 24498331
[TBL] [Abstract][Full Text] [Related]
25. Channel Activity of Cardiac Ryanodine Receptors (RyR2) Determines Potency and Efficacy of Flecainide and R-Propafenone against Arrhythmogenic Calcium Waves in Ventricular Cardiomyocytes.
Savio-Galimberti E; Knollmann BC
PLoS One; 2015; 10(6):e0131179. PubMed ID: 26121139
[TBL] [Abstract][Full Text] [Related]
26. Divergent regulation of ryanodine receptor 2 calcium release channels by arrhythmogenic human calmodulin missense mutants.
Hwang HS; Nitu FR; Yang Y; Walweel K; Pereira L; Johnson CN; Faggioni M; Chazin WJ; Laver D; George AL; Cornea RL; Bers DM; Knollmann BC
Circ Res; 2014 Mar; 114(7):1114-24. PubMed ID: 24563457
[TBL] [Abstract][Full Text] [Related]
27. Accentuated vagal antagonism paradoxically increases ryanodine receptor calcium leak in long-term exercised Calsequestrin2 knockout mice.
Ho HT; Thambidorai S; Knollmann BC; Billman GE; Györke S; Kalyanasundaram A
Heart Rhythm; 2018 Mar; 15(3):430-441. PubMed ID: 29030236
[TBL] [Abstract][Full Text] [Related]
28. Uptake-leak balance of SR Ca
Lopez R; Janicek R; Fernandez-Tenorio M; Courtehoux M; Matas L; Gerbaud P; Gomez AM; Egger M; Niggli E
J Mol Cell Cardiol; 2022 Sep; 170():1-14. PubMed ID: 35644481
[TBL] [Abstract][Full Text] [Related]
29. Distinct mechanisms mediate pacemaker dysfunction associated with catecholaminergic polymorphic ventricular tachycardia mutations: Insights from computational modeling.
Arbel-Ganon L; Behar JA; Gómez AM; Yaniv Y
J Mol Cell Cardiol; 2020 Jun; 143():85-95. PubMed ID: 32339564
[TBL] [Abstract][Full Text] [Related]
30. Role of SERCA and the sarcoplasmic reticulum calcium content on calcium waves propagation in rat ventricular myocytes.
Salazar-Cantú A; Pérez-Treviño P; Montalvo-Parra D; Balderas-Villalobos J; Gómez-Víquez NL; García N; Altamirano J
Arch Biochem Biophys; 2016 Aug; 604():11-9. PubMed ID: 27242324
[TBL] [Abstract][Full Text] [Related]
31. Allele-Specific Silencing of Mutant mRNA Rescues Ultrastructural and Arrhythmic Phenotype in Mice Carriers of the R4496C Mutation in the Ryanodine Receptor Gene (
Bongianino R; Denegri M; Mazzanti A; Lodola F; Vollero A; Boncompagni S; Fasciano S; Rizzo G; Mangione D; Barbaro S; Di Fonso A; Napolitano C; Auricchio A; Protasi F; Priori SG
Circ Res; 2017 Aug; 121(5):525-536. PubMed ID: 28620067
[TBL] [Abstract][Full Text] [Related]
32. Arrhythmogenesis in a catecholaminergic polymorphic ventricular tachycardia mutation that depresses ryanodine receptor function.
Zhao YT; Valdivia CR; Gurrola GB; Powers PP; Willis BC; Moss RL; Jalife J; Valdivia HH
Proc Natl Acad Sci U S A; 2015 Mar; 112(13):E1669-77. PubMed ID: 25775566
[TBL] [Abstract][Full Text] [Related]
33. Constitutive Intracellular Na+ Excess in Purkinje Cells Promotes Arrhythmogenesis at Lower Levels of Stress Than Ventricular Myocytes From Mice With Catecholaminergic Polymorphic Ventricular Tachycardia.
Willis BC; Pandit SV; Ponce-Balbuena D; Zarzoso M; Guerrero-Serna G; Limbu B; Deo M; Camors E; Ramirez RJ; Mironov S; Herron TJ; Valdivia HH; Jalife J
Circulation; 2016 Jun; 133(24):2348-59. PubMed ID: 27169737
[TBL] [Abstract][Full Text] [Related]
34. Purkinje cells from RyR2 mutant mice are highly arrhythmogenic but responsive to targeted therapy.
Kang G; Giovannone SF; Liu N; Liu FY; Zhang J; Priori SG; Fishman GI
Circ Res; 2010 Aug; 107(4):512-9. PubMed ID: 20595652
[TBL] [Abstract][Full Text] [Related]
35. Ca(2+) wave probability is determined by the balance between SERCA2-dependent Ca(2+) reuptake and threshold SR Ca(2+) content.
Stokke MK; Briston SJ; Jølle GF; Manzoor I; Louch WE; Øyehaug L; Christensen G; Eisner DA; Trafford AW; Sejersted OM; Sjaastad I
Cardiovasc Res; 2011 Jun; 90(3):503-12. PubMed ID: 21242164
[TBL] [Abstract][Full Text] [Related]
36. Calcium/calmodulin-dependent kinase II and nitric oxide synthase 1-dependent modulation of ryanodine receptors during β-adrenergic stimulation is restricted to the dyadic cleft.
Dries E; Santiago DJ; Johnson DM; Gilbert G; Holemans P; Korte SM; Roderick HL; Sipido KR
J Physiol; 2016 Oct; 594(20):5923-5939. PubMed ID: 27121757
[TBL] [Abstract][Full Text] [Related]
37. Modeling of catecholaminergic polymorphic ventricular tachycardia with patient-specific human-induced pluripotent stem cells.
Itzhaki I; Maizels L; Huber I; Gepstein A; Arbel G; Caspi O; Miller L; Belhassen B; Nof E; Glikson M; Gepstein L
J Am Coll Cardiol; 2012 Sep; 60(11):990-1000. PubMed ID: 22749309
[TBL] [Abstract][Full Text] [Related]
38. I(CaL) inhibition prevents arrhythmogenic Ca(2+) waves caused by abnormal Ca(2+) sensitivity of RyR or SR Ca(2+) accumulation.
Stokke MK; Tovsrud N; Louch WE; Øyehaug L; Hougen K; Sejersted OM; Swift F; Sjaastad I
Cardiovasc Res; 2013 May; 98(2):315-25. PubMed ID: 23417043
[TBL] [Abstract][Full Text] [Related]
39. The oxidation-resistant CaMKII-MM281/282VV mutation does not prevent arrhythmias in CPVT1.
Sadredini M; Manotheepan R; Lehnart SE; Anderson ME; Sjaastad I; Stokke MK
Physiol Rep; 2021 Sep; 9(18):e15030. PubMed ID: 34558218
[TBL] [Abstract][Full Text] [Related]
40. The mechanism of flecainide action in CPVT does not involve a direct effect on RyR2.
Bannister ML; Thomas NL; Sikkel MB; Mukherjee S; Maxwell C; MacLeod KT; George CH; Williams AJ
Circ Res; 2015 Apr; 116(8):1324-35. PubMed ID: 25648700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
